Why is Remedium Life falling/rising?

As of 05-Sep, Remedium Lifecare Ltd's stock price is currently at 1.44, reflecting an increase of 0.12 or 9.09%. The stock has shown strong performance recently, outperforming its sector by 8.56% today and achieving a consecutive gain over the last two days with a total return of 12.5%. Over the past week, the stock has risen by 9.92%, and in the last month, it has increased by 13.39%. However, despite these short-term gains, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times and a reported decline in net sales of -76.36%. These negative factors contribute to a poor long-term growth outlook, as the company has reported losses for the last four consecutive quarters and has a negative return on capital employed.
In the broader market context, while the stock has performed well in the short term, it has underperformed significantly over the past year, with a return of -79.37% compared to the Sensex's decline of only -1.81%. This stark contrast highlights the stock's volatility and the risks associated with its financial health. The recent gains may be attributed to short-term trading activity rather than a fundamental recovery, as indicated by falling investor participation and a liquidity level that suggests caution among traders. Overall, while the stock is experiencing a temporary rise, the underlying financial issues and poor long-term performance present a challenging outlook.